Correlation Between Sartorius Stedim and Teleperformance

Can any of the company-specific risk be diversified away by investing in both Sartorius Stedim and Teleperformance at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Sartorius Stedim and Teleperformance into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Sartorius Stedim Biotech and Teleperformance SE, you can compare the effects of market volatilities on Sartorius Stedim and Teleperformance and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Sartorius Stedim with a short position of Teleperformance. Check out your portfolio center. Please also check ongoing floating volatility patterns of Sartorius Stedim and Teleperformance.

Diversification Opportunities for Sartorius Stedim and Teleperformance

-0.04

Correlation Coefficient

Sartorius Stedim  Teleperformance

Good diversification

The 3 months correlation between Sartorius and Teleperformance is -0.04. Overlapping area represents the amount of risk that can be diversified away by holding Sartorius Stedim Biotech and Teleperformance SE in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Teleperformance SE and Sartorius Stedim is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Sartorius Stedim Biotech are associated (or correlated) with Teleperformance. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Teleperformance SE has no effect on the direction of Sartorius Stedim i.e., Sartorius Stedim and Teleperformance go up and down completely randomly.

Pair Corralation between Sartorius Stedim and Teleperformance

Assuming the 90 days trading horizon Sartorius Stedim Biotech is expected to under-perform the Teleperformance. But the stock apears to be less risky and, when comparing its historical volatility, Sartorius Stedim Biotech is 1.74 times less risky than Teleperformance. The stock trades about -0.01 of its potential returns per unit of risk. The Teleperformance SE is currently generating about 0.02 of returns per unit of risk over similar time horizon. If you would invest  8,491  in Teleperformance SE on April 20, 2025 and sell it today you would earn a total of  131.00  from holding Teleperformance SE or generate 1.54% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Sartorius Stedim Biotech  vs.  Teleperformance SE

Sartorius Stedim Biotech

Risk-Adjusted Performance

Very Weak

Over the last 90 days Sartorius Stedim Biotech has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong primary indicators, Sartorius Stedim is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.

Teleperformance SE

Risk-Adjusted Performance

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in Teleperformance SE are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. Despite somewhat strong basic indicators, Teleperformance is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.

Pair Trading with Sartorius Stedim and Teleperformance

The main advantage of trading using opposite Sartorius Stedim and Teleperformance positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Sartorius Stedim position performs unexpectedly, Teleperformance can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Teleperformance will offset losses from the drop in Teleperformance's long position.

The idea behind Sartorius Stedim Biotech and Teleperformance SE pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Analyst Advice module to analyst recommendations and target price estimates broken down by several categories.